DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Spironolactone and Hydrochlorothiazide (Spironolactone / Hydrochlorothiazide) - Published Studies

 
 



Published Studies Related to Spironolactone and Hydrochlorothiazide (Spironolactone / Hydrochlorothiazide)

Well-designed clinical trials related to Spironolactone and Hydrochlorothiazide (Spironolactone / Hydrochlorothiazide)

Spironolactone and hydrochlorothiazide decrease vascular stiffness and blood pressure in geriatric hypertension. [2010.07]

Spironolactone and hydrochlorothiazide decrease vascular stiffness and blood pressure in geriatric hypertension. [2010]

Comparison of effects of low dose of spironolactone and a thiazide diuretic in patients with hypertension treated with an angiotensin-converting enzyme inhibitor or an angiotensin type 1 receptor blocker. [2009.11]

Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism. [2008.03]

The effect of spironolactone, cilazapril and their combination on albuminuria in patients with hypertension and diabetic nephropathy is independent of blood pressure reduction: a randomized controlled study. [2004.05]

Spironolactone abolishes the relationship between aldosterone and plasminogen activator inhibitor-1 in humans. [2002.02]

A comparison of the potassium and magnesium-sparing properties of amiloride and spironolactone in diuretic-treated normal subjects. [1993.04]

Hydrochlorothiazide versus spironolactone: long-term metabolic modifications in patients with essential hypertension. [1991.05]

Effect of spironolactone-hydrochlorothiazide on lung function in infants with chronic bronchopulmonary dysplasia. [1989.04]

Well-designed clinical trials possibly related to Spironolactone and Hydrochlorothiazide (Spironolactone / Hydrochlorothiazide)

Pharmacotherapy review of chronic pediatric hypertension. [2011.10]

Impact of aldosterone receptor blockade compared with thiazide therapy on sympathetic nervous system function in geriatric hypertension. [2010.05]

Triple pharmacological blockade of the renin-angiotensin-aldosterone system in nondiabetic CKD: an open-label crossover randomized controlled trial. [2008.09]

Triple Pharmacological Blockade of the Renin-Angiotensin-Aldosterone System in Nondiabetic CKD: An Open-Label Crossover Randomized Controlled Trial. [2008.04.17]

Beneficial effects of eplerenone versus hydrochlorothiazide on coronary circulatory function in patients with diabetes mellitus. [2007.07]

Randomized, placebo-controlled trial of the effects of drospirenone-estradiol on blood pressure and potassium balance in hypertensive postmenopausal women receiving hydrochlorothiazide. [2007.05]

Randomized, placebo-controlled trial of the effects of drospirenone-estradiol on blood pressure and potassium balance in hypertensive postmenopausal women receiving hydrochlorothiazide. [2007.01.11]

Effect of various diuretic treatments on rosiglitazone-induced fluid retention. [2006.12]

Effects of eplerenone versus losartan in patients with low-renin hypertension. [2005.09]

Differing effects of mineralocorticoid receptor-dependent and -independent potassium-sparing diuretics on fibrinolytic balance. [2005.08]

Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study. [2003.10.14]

Comparison of two oral electrolyte solutions for the treatment of dehydrated calves with experimentally-induced diarrhoea. [2001.09]

The Eurevie Study: contrasting effect of piretanide and thiazides in mild to moderate hypertension. [1997.05]

A randomized comparison of the effect of two diuretics, a converting enzyme inhibitor, and a sympathomimetic amine on weight loss in diet-refractory patients. [1995.09]

Randomized, double-blind, controlled trial of long-term diuretic therapy for bronchopulmonary dysplasia. [1989.10]

Other research related to Spironolactone and Hydrochlorothiazide (Spironolactone / Hydrochlorothiazide)

Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase-2 activity and expression in a model of renovascular hypertension. [2010.05]

[Impact of patient compliance on the outcomes in hypertensive patients receiving hydrochlorothiazide based combination therapy with spironolactone or captopril.] [2008.12]

Long-term metabolic effects of spironolactone and thiazides combined with potassium-sparing agents for treatment of essential hypertension. [1988.11.15]

Other possibly related research studies

Low-dose aldosterone blockade as a new treatment paradigm for controlling resistant hypertension. [2007.01]

The effects of thiazide and thiazide-potassium sparing diuretics on fibrinolytic system parameters. [2006.06]

Angiotensin-converting enzyme inhibitors and obstructive sleep apnea. [2006.01]

Regression of existing glomerulosclerosis by inhibition of aldosterone. [2005.11]

[A patient with severe hyperkalaemia -- an emergency after RALES] [2005.09.09]

Aldosterone antagonism: an emerging strategy for effective blood pressure lowering. [2005.06]

A meta-analytical approach to the efficacy of antihypertensive drugs in reducing blood pressure. [2005]

Normal pregnancy outcome following inadvertent exposure to rosiglitazone, gliclazide, and atorvastatin in a diabetic and hypertensive woman. [2004.06]

A reliable, practical, and economical protocol for inducing diarrhea and severe dehydration in the neonatal calf. [1998.07]

Clinical and laboratory assessment of hydration status of neonatal calves with diarrhea. [1998.04.01]

Hyperkalaemia and diarrhoea in a patient with surreptitious ingestion of potassium sparing diuretics. [1997.10]

Are prescribing patterns of diuretics in general practice good enough? A report from the More & Romsdal Prescription Study. [1997.03]

Serum lipoproteins during treatment with antihypertensive drugs. [1993]

Effect of diuretics on the plasma lipid profile. [1992.12]

Characterization of a novel aquaretic agent, OPC-31260, as an orally effective, nonpeptide vasopressin V2 receptor antagonist. [1992.04]

Combination antihypertensive therapy with terazosin and other antihypertensive agents: results of clinical trials. [1991.09]

[Effect of captopril therapy on sodium and water excretion in patients with liver cirrhosis and ascites] [1989.08.01]

[Respiratory insufficiency in mucoviscidosis. Pathophysiologic aspects of conservative drug therapy] [1989.01]

Mineral excretion in premature infants receiving various diuretic therapies. [1988.09]

Clinical implications of primary aldosteronism with resistant hypertension. [1988.02]

[Studies on the bioequivalence of canrenone using pharmacokinetic data and clinical effects] [1987.09.15]

Update of diuretics in the treatment of hypertension. [2007.03]

Updated meta-analytical approach to the efficacy of antihypertensive drugs in reducing blood pressure. [2007]

Potent diuretic effects of prednisone in heart failure patients with refractory diuretic resistance. [2007.09]

Metabolic syndrome: treatment of hypertensive patients. [2007.07]

Thiazolidinediones and their fluid-related adverse effects: facts, fiction and putative management strategies. [2007]

Hypertension induces somatic cellular senescence in rats and humans by induction of cell cycle inhibitor p16INK4a. [2008.07]

Increased renoprotection with ACE inhibitor plus aldosterone antagonist as compared to monotherapies--the effect on podocytes. [2009.08.08]

Blood pressure versus direct mineralocorticoid effects on kidney inflammation and fibrosis in DOCA-salt hypertension. [2008.11]

Increased renoprotection with ACE inhibitor plus aldosterone antagonist as compared to monotherapies--the effect on podocytes. [2009.12]

Effects of hydrochlorothiazide on cardiac remodeling in a rat model of myocardial infarction-induced congestive heart failure. [2011.09.30]

Evidence-based diuretic therapy for improving cardiovascular prognosis in systemic hypertension. [2011.04.15]

Impact of aldosterone receptor blockade compared with thiazide therapy on sympathetic nervous system function in geriatric hypertension. [2010]

Mineralocorticoid receptor blockade improves coronary microvascular function in individuals with type 2 diabetes. [2015]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017